THE NEWSROOM

Search
Categories
Archives

Investment Monitoring From Robbins LLP

To ensure your financial investments are being managed honestly, enroll in Stock Watch, our free investment monitoring service for individual and institutional investors.
Class Actions

Sionna Therapeutics Investigation

Robbins LLP is investigating Sionna Therapeutics (NASDAQ: SION) to determine whether certain Sionna Therapeutics officers and directors violated securities laws and breached fiduciary duties to shareholders.  Robbins LLP is investigating Sionna

Read More
Class Actions

Suja Life, Inc. Investigation

Robbins LLP is Investigating Suja Life, Inc. (NASDAQ: SUJA) to Determine Whether Certain Suja LIfe, Inc. Officers and Directors Violated Securities Laws and Breached Fiduciary Duties to Shareholders Robbins LLP is

Read More
Class Actions

Aardvark Therapeutics, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Aardvark Therapeutics, Inc. Misled Investors Regarding the Viability and Efficacy of its Lead Drug Candidate ARD-101  Robbins LLP informs investors that a class action was

Read More
Class Actions

Blaize Holdings, Inc. Investigation

Robbins LLP is Investigating the Recent Stock Drop of Blaize Holdings, Inc. Robbins LLP is investigating Blaize Holdings, Inc. (NASDAQ: BZAI) to determine whether certain Blaize Holdings, Inc. officers and directors

Read More
Class Actions

HDFC Bank Limited Class Action Lawsuit

Robbins LLP is Investigating Allegations that HDFC Bank Limited Camouflaged Payments as Marketing Spend to Pay Higher Interest to a State Firm to Induce Deposits Robbins LLP informs investors that a

Read More
Finances Saving Economy concept
Class Actions

UWM Holdings Corporation Class Action Lawsuit

Robbins LLP is Investigating Allegations that UWM Holdings Corporation Over-Hedged Itself in Anticipation of its Acquisition of Two Harbors Investment Corp. Robbins LLP informs investors that a class action was filed

Read More
Class Actions

Replimune Group Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Replimune Group, Inc. Misled Investors Regarding the Efficacy and Viability of its Lead Product Candidate RP1 Robbins LLP informs investors that a class action was

Read More
Skip to content